Institutional members access full text with Ovid®

Share this article on:

Evaluation of the Child With Suspected Mitochondrial Liver Disease

Molleston, Jean P.*; Sokol, Ronald J.; Karnsakul, Wikrom; Miethke, Alexander§; Horslen, Simon||; Magee, John C.; Romero, René#; Squires, Robert H.**; Van Hove, Johan L.K.††; for the Childhood Liver Disease Research Education Network (ChiLDREN)


In the article that published in the September 2013 issue on page 269, a drug name was changed in error. The sentence on page 275 should read instead: “It is important to discontinue or avoid medications that may exacerbate hepatopathy or impair mitochondrial function or mtDNA translation or transcription, including sodium valproate, tetracycline, and macrolide antibiotics, reverse transcriptase inhibitors (particularly AZT), chloramphenicol, quinolones, and linezolid (48).”

Journal of Pediatric Gastroenterology and Nutrition. 59(3):340, September 2014.

Journal of Pediatric Gastroenterology & Nutrition: September 2013 - Volume 57 - Issue 3 - p 269–276
doi: 10.1097/MPG.0b013e31829ef67a
Invited Reviews